- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
Selected policies on adolescent friendly health services in low and middle income countries - information from countries that responded to the Global Maternal, Newborn, Child and Adolescent Health Policy Indicator Surveys (2009-10, 2011-12 and 2013-14) undertaken by Department of Maternal, Newborn, Child and Adolescent Health; World Health
|Download Data Sheet|
HIV treatment is a cornerstone of the AIDS response, helping to prevent AIDS-related deaths and avert new infections. It also helps people living with HIV to live close-to-normal lifespans, thereby reducing HIV-related stigma. Evidence shows that HIV treatment, administered ideally as soon as possible after diagnosis, not only slows disease progression but also prevents onward HIV transmission. Moreover, the right to the highest attainable standard of health necessitates access to treatment and other medicines to ensure that people living with HIV can have long and productive lives.
Keywords: HIV, treatment, human rights, Fast-Track, medicines, financing
In this brief, we review drug pricing for new hepatitis C medications and pose basic questions of fairness and medical ethics. Although we focus on Gilead and its hepatitis C drug sofosbuvir, the issues we highlight are broadly applicable to other manufacturers of hepatitis C medications.
The Board is presenting this special report to Member States in the hope that the analysis and recommendations presented therein may assist them in the development of national policies and control systems that are capable of achieving the goals of the international drug control conventions in relation to ensuring availability of narcotic drugs and psychotropic substances. Member States have already underlined the importance of this issue in a number of resolutions and political declarations adopted by the Commission on Narcotic Drugs. They also referred to it in the Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases and in resolution WHA67.19 of the World Health Assembly, on strengthening of palliative care as a component of comprehensive care throughout the life course.
Keywords: HIV/AIDS, law enforcement, medicines, drug
This document provides Cohort analysis for patients who started ART in 2013 (12 months), Cohort analysis for patients who started ART in 2012 (24 months) and Cohort analysis for patients who started ART in 2009 (60 months).
Keywords: ART, treatment, clinic, deaths
To reduce new HIV infections globally to fewer than 500 000 by 2020, a step towards ending the HIV epidemic as a public health threat by 2030, we need to Fast-Track the response, including renewed commitment to, sustained funding for and scaled-up implementation of HIV prevention programmes.
Keywords: HIV prevention, young women, partners, PrEP, male circumcision
WHO guidelines on antiretroviral therapy (ART) have evolved during the past decade towards recommending earlier treatment, as evidence has shown clinical and public health benefit, treatment has become simpler, more tolerable and more affordable, and systems for ARV delivery have been streamlined for scale.
This update summarizes experiences of countries that have already begun to implement earlier treatment approaches as part of a national policy or pilot programmes. Overall, these five country examples demonstrate that scaling up a treat-all policy, across diverse populations (adults, key populations and children) is acceptable and feasible, with early benefits and no immediate evidence of harmful effects.
The present document aims to review the progress of the HIV response in the Asia-Pacific region, with a view to identifying the opportunities for further action afforded by the 2011 Political Declaration. In doing so, it also draws on the expressed commitments undertaken by ESCAP member States to address the HIV epidemic, including those reflected in resolutions 66/10, Regional call for action to achieve universal access to HIV prevention, treatment, care and support in Asia and the Pacific (19 May 2010) and 67/9, Asia-Pacific regional review of the progress achieved in realizing the Declaration of Commitment on HIV/AIDS and the Political Declaration on HIV/AIDS (25 May 2011).
Keywords: IGM, 2015, HIV, prevalence, treatment, care, prevention, gender, violence, ART, children, women
Surveillance of transmitted HIV drug resistance (TDR) in individuals recently infected with HIV was performed following WHO-suggested methods. The prevalence of transmitted HIV drug resistance (TDR) in recently infected antiretroviral drug naïve individuals in PNG has not been fully characterised.
Preventing HIV Transmission in Intimate Partner Relationships: Evidence, strategies and approaches for addressing concentrated HIV epidemics in Asia provides evidence-based guidance to policymakers in Asia so that national HIV responses give appropriate priority to prevention efforts among key populations and their intimate partners, as well as those in serodiscordant relationships. Scaling up efforts to prevent intimate partner transmission of HIV will help countries to meet targets to halve sexual transmission of HIV, eliminate mother-to-child transmission, reduce AIDS-related maternal deaths, and address gender inequalities.
Download summary report click here
Download infographics on